CJC-1295

Research

CJC-1295 (with/without DAC)

Category
Growth Hormone
Aliases
DAC:GRF, Modified GRF 1-29
Administration
Subcutaneous injection

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Water retention

A temporary increase in fluid retention, common with compounds that elevate growth hormone.

Tingling extremities

A temporary tingling sensation in the hands or feet reported by some users.

Increased hunger

Reflects this compound's activity on the same receptor pathway used by the body's natural hunger hormone.

Fatigue

A sense of tiredness reported by some users, particularly during initial use.